1. Home
  2. ZJYL vs NEPH Comparison

ZJYL vs NEPH Comparison

Compare ZJYL & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JIN MEDICAL INTERNATIONAL LTD.

ZJYL

JIN MEDICAL INTERNATIONAL LTD.

HOLD

Current Price

$0.24

Market Cap

40.5M

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$5.41

Market Cap

46.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZJYL
NEPH
Founded
2006
1997
Country
China
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.5M
46.8M
IPO Year
2023
2004

Fundamental Metrics

Financial Performance
Metric
ZJYL
NEPH
Price
$0.24
$5.41
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
1.7M
75.0K
Earning Date
08-20-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
0.14
Revenue
$22,826,624.00
$17,930,000.00
Revenue This Year
N/A
$24.38
Revenue Next Year
N/A
$10.16
P/E Ratio
$21.46
$38.10
Revenue Growth
13.42
32.36
52 Week Low
$0.22
$1.39
52 Week High
$1.42
$6.42

Technical Indicators

Market Signals
Indicator
ZJYL
NEPH
Relative Strength Index (RSI) 31.88 54.24
Support Level $0.24 $4.50
Resistance Level $0.28 $5.63
Average True Range (ATR) 0.02 0.59
MACD 0.01 0.04
Stochastic Oscillator 9.83 52.67

Price Performance

Historical Comparison
ZJYL
NEPH

About ZJYL JIN MEDICAL INTERNATIONAL LTD.

Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: